Promoter group inter-se transfer of 15.20 percent stake in Sanofi India

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.8%Reaction day

₹3022.00

prior close

₹3032.30

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.8%+0.9% vs market

Pharmaceuticals peers, median of 172sector-2.5%+0.7% vs sector

On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 0.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.9

15m

-0.9

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.8-2.8+0.9-2.5+0.7

Next day

-2.7-2.5-0.2-2.6-0.1

-3.2-1.7-1.5-2.5-0.7

-2.0-1.5-0.5-2.6+0.6

-1.3-0.8-0.5-2.5+1.2

-2.3-2.4+0.1-3.2+0.9

-4.8-3.4-1.4-4.3-0.5

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sanofi Healthcare India (promoter group entity) acquired 35 lakh shares (15.20 percent) from Hoechst GmbH on 24 Sep 2026 at Rs 3,052 per share via block deal. Total deal value about Rs 107 crore. This is an inter-se transfer within the promoter group, both ultimately held by Sanofi France, so the aggregate promoter holding stays unchanged at 60.40 percent. Exempted from open offer under Regulation 10(1)(a)(iii). Price was below the 60-day VWAP of Rs 3,228.

Likely market impact

No change in total promoter stake, no open offer triggered. Neutral for minority shareholders.